Literature DB >> 7684003

Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study.

K E Bakkevold1, B Kambestad.   

Abstract

Between 1984-1987, 472 Norwegian patients with histologically or cytologically verified adenocarcinoma of the pancreas (n = 442) and papilla of Vater (n = 30) were prospectively accrued. Radical surgery, i.e. Whipple's procedure (n = 80) or total pancreatectomy (n = 28) were performed in 19% and 80% of patients with pancreatic and papilla carcinoma, respectively. The 1- and 5-year survival rate of patients with pancreatic and papilla carcinoma were 15 and 0.2%, median survival 4.5 months; and 66 and 15%, median survival 17 months, respectively. The corresponding results following radical surgery of pancreatic carcinoma were 45 and 1%, median survival 11.4 months; of papilla carcinoma 78 and 20%, median survival 38.1 months. Radical surgery or a palliative bypass of pancreatic carcinoma were followed by a mean survival of 20.1 vs 9.1 months (P = 0.03) in Stage I and 15.1 vs 7.5 months (P = 0.004) in Stage III, respectively. A Whipple's operation and total pancreatectomy were followed by a mean survival of 16.7 and 18.3 months (P = 0.5), respectively. Dismal prognostic factors were: a distal tumour site, high TNM stage grouping and weight loss. Beneficial factors were a high Karnofsky's index and radical surgery.

Entities:  

Mesh:

Year:  1993        PMID: 7684003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

1.  Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases.

Authors:  A Dorandeu; J L Raoul; F Siriser; N Leclercq-Rioux; M Gosselin; E D Martin; M P Ramée; B Launois
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  Controversial issues in the management of pancreatic cancer: Part Two. A debate held at St Mary's Hospital, London on 18 November 1993.

Authors:  G Glazer; C Coulter; M E Crofton; W M Gedroyc; C D Johnson; C N Mallinson; R C Russell; M L Steer; J A Summerfield; R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

3.  Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas.

Authors:  H Friess; L Wang; Z Zhu; R Gerber; M Schröder; A Fukuda; A Zimmermann; M Korc; M W Büchler
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

4.  Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma.

Authors:  Naoyuki Yokoyama; Yoshio Shirai; Toshifumi Wakai; Shigenori Nagakura; Kohei Akazawa; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

Review 5.  Preoperative combined modality therapy for pancreatic cancer.

Authors:  T A Rich; D B Evans
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

6.  Staging of carcinoma of the pancreas and ampulla of Vater. Tumor (T), lymph node (N), and distant metastasis (M) as prognostic factors.

Authors:  K E Bakkevold; B Kambestad
Journal:  Int J Pancreatol       Date:  1995-06

7.  Analysis of long-term survivors after surgical resection for invasive pancreatic cancer.

Authors:  Shigehiro Kure; Tetsuya Kaneko; Shin Takeda; Soichiro Inoue; Akimasa Nakao
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

8.  Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

Authors:  S S Nitecki; M G Sarr; T V Colby; J A van Heerden
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

Review 9.  Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.

Authors:  Masahiro Tanemura; Eiji Miyoshi; Hiroaki Nagano; Hidetoshi Eguchi; Katsuyoshi Matsunami; Kiyomi Taniyama; Nobutaka Hatanaka; Hiroki Akamatsu; Masaki Mori; Yuichiro Doki
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

10.  The time of occurrence of liver metastasis in carcinoma of the pancreas.

Authors:  K Amikura; M Kobari; S Matsuno
Journal:  Int J Pancreatol       Date:  1995-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.